Table 2.
95% Limits of Agreement | |||||||||
---|---|---|---|---|---|---|---|---|---|
Value | (Mean ± SD) | d | ICC | R2 | SEE | CE ± 1.96 SD | Upper | Lower | Trend |
DXABF% | 34.63 ± 8.03 | --- | |||||||
InBody BF% | 31.47 ± 9.35 | 1.15 | 0.94 | 0.92 | 2.23 | −3.16 ± 5.41 | 2.25 | −8.57 | 0.48 |
DXA FM | 22.61 ± 10.75 | --- | |||||||
InBody FM | 21.64 ± 12.01 | 0.53 | 0.97 | 0.98 | 1.28 | −0.98 ± 3.61 | 2.63 | −4.59 | 0.68 |
DXA FFM | 42.56 ± 6.84 | --- | |||||||
InBody FFM | 43.50 ± 6.20 | 0.55 | 0.98 | 0.94 | 1.66 | 0.94 ± 3.35 | 4.29 | −2.41 | −0.38 |
DXA = Dual-energy x-ray absorptiometry; InBody 570 = Multi-frequency bioelectrical impedance; BF% = body fat percentage; FFM = fat-free mass; SEE = standard error of estimate; CE = constant error.